tert-Butyl 2-chloro-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate, 97%, 100mg

(2S,4S)-4-(Benzyloxy)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 98%, 1g

Methyl 1-oxo-1,3-dihydroisobenzofuran-5-carboxylate, 95.0%, 1g

6-Bromo-3-methoxy-2-nitropyridine, 98%, 10g

2,3-DIHYDRO-1H-INDENE-4-CARBALDEHYDE, 95.0%, 100mg

h-glu(oet)-oh, 98.0%, 1g

5-((5-(Trifluoromethyl)pyridin-2-yl)oxy)thiazol-2-amine, 97%, 250mg

2-(3,4-Dichlorobenzenesulfonamido)benzoic acid, 97%, 250mg

NAD, mínimo 95 %, para bioquímica, 5 g, envase de vidrio

6-(Difluoromethoxy)picolinic acid, 95.0%, 1g

(S)-tert-Butyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate, 95.0%, 25g

(6-Bromobenzo[d][1,3]dioxol-5-yl)methanol, 95.0%, 5g

5-Bromo-3-chloro-2-hydroxybenzaldehyde, 95.0%, 250mg